Male Breast Carcinoma Active Not Recruiting Phase 1 Trials for Dinaciclib (DB12021)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01624441Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerTreatment